Disease: Progressive supranuclear palsy
- A Blinded Evaluation of Brain Morphometry for Differential Diagnosis of Atypical Parkinsonism
- Aberrant dynamic functional network connectivity in progressive supranuclear palsy
- Accuracy of routinely collected hospital administrative discharge data and death certificate ICD-10 diagnostic coding in progressive supranuclear palsy and corticobasal syndrome: a systematic review and validation study
- Alexander disease with a novel GFAP insertion-deletion mutation mimicking progressive supranuclear palsy
- Amyloid-β prediction machine learning model using source-based morphometry across neurocognitive disorders
- Anti-alpha synuclein and anti-tau immunotherapies: Can a cocktail approach work?
- APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathology
- Association of Insulin-like Growth Factor-1 and Neurofilament Light Chain in Patients with Progressive Supranuclear Palsy
- Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia
- Association of Structural Forms of 17q21.31 with the Risk of Progressive Supranuclear Palsy and MAPT Sub-haplotypes
- Cerebral tau deposition in co-morbid progressive supranuclear palsy and amyotrophic lateral sclerosis: an [18F]-flortaucipir and 7T MRI study
- Challenges to Distinguish Idiopathic Normal Pressure Hydrocephalus from Progressive Supranuclear Palsy
- Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias
- Clinical and Pathological Features of FTDP-17 with MAPT p.K298_H299insQ Mutation
- Clinical features and effects of shunt surgery in patients with progressive supranuclear palsy and idiopathic normal pressure hydrocephalus
- Clinical Utility of Tectal Plate Measurements on Magnetic Resonance Imaging in Progressive Supranuclear Palsy
- Clinicopathological study of dementia with grains presenting with parkinsonism compared with a typical case
- Clinicoradiological and neuropathological evaluation of primary progressive aphasia
- Colocalization of Increased Midbrain Signals in Neuroinflammation and Tau PET Imaging Suggests the Diagnosis of Progressive Supranuclear Palsy
- Complemental Value of Microstructural and Macrostructural MRI in the Discrimination of Neurodegenerative Parkinson Syndromes
- Concomitant Medications for Progressive Supranuclear Palsy: A Secondary Analysis of a Randomized Clinical Trial
- Contribution of MRI for the Early Diagnosis of Parkinsonism in Patients with Diagnostic Uncertainty
- Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy
- Correlation with sympathetic skin response, <sup>123</sup>I-MIBG scintigraphy, and <sup>123</sup>I-FP-CIT SPECT in Parkinson's disease
- Cortico-basal syndrome and cortico-basal degeneration: From the clinical diagnosis to the lesional substrate for an adapted care
- Corticobasal degeneration with visual hallucination as an initial symptom: A case report
- Deep Learning-based Approach for Brainstem and Ventricular MR Planimetry: Application in Patients with Progressive Supranuclear Palsy
- Deep vein thrombosis and its risk factors in neurodegenerative diseases: A markedly higher incidence in Parkinson's disease
- Detecting Abnormal Eye Movements in Patients with Neurodegenerative Diseases - Current Insights
- Detecting and Validating MAPT Mutations in Neurodegeneration Patients and Analysis of Exon Splicing Consequences
- Diagnostic value of isolated plasma biomarkers and its combination in neurodegenerative dementias: A multicenter cohort study
- Differential Synaptic Loss in β-Amyloid Positive Versus β-Amyloid Negative Corticobasal Syndrome
- Diplopia in Movement Disorders: A Systematic Review of the Literature
- Direct Current Stimulation of Prefrontal Cortex Is Not Effective in Progressive Supranuclear Palsy: A Randomized Trial
- Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies
- Disentangling tau: One protein, many therapeutic approaches
- Dissecting the Clinical Heterogeneity and Genotype-Phenotype Correlations of <em>MAPT</em> Mutations: A Systematic Review
- Dominance of Tau Burden in Cortical Over Subcortical Regions Mediates Glymphatic Activity and Clinical Severity in PSP
- Dysphagia Prevalence in Progressive Supranuclear Palsy: A Systematic Review and Meta-Analysis
- Evaluating the Effect of Alzheimer's Disease-Related Biomarker Change in Corticobasal Syndrome and Progressive Supranuclear Palsy
- Evaluation of cerebrospinal fluid alpha-synuclein seed amplification assay in PSP and CBS
- Extracellular vesicles contain filamentous alpha-synuclein and facilitate the propagation of Parkinson's pathology
- First-In-Human Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of AZP2006, A Synthetic Compound for the Treatment of Alzheimer's Disease and Related Diseases
- Flanagan's condensed protocol for neurodegenerative diseases. Implementation in a clinical autopsy setting with partial supervision of a neuropathologist
- Free water imaging in Parkinson's disease and atypical parkinsonian disorders
- Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism
- Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants
- Gene specific effects on brain volume and cognition of <em>TMEM106B</em> in frontotemporal lobar degeneration
- Genetic forms of tauopathies: inherited causes and implications of Alzheimer's disease-like TAU pathology in primary and secondary tauopathies
- Glucose Metabolism and Cognitive Decline in Progressive Supranuclear Palsy and Corticobasal Syndrome: A Preliminary Study
- Histologic tau lesions and magnetic resonance imaging biomarkers differ across two progressive supranuclear palsy variants
- How can we manage progressive supranuclear palsy syndrome with pharmacotherapy?
- Human biodistribution and radiation dosimetry for the tau tracer [<sup>18</sup>F]Florzolotau in healthy subjects
- Human iPSC 4R tauopathy model uncovers modifiers of tau propagation
- Huntingtin CAG repeats in neuropathologically confirmed tauopathies: Novel insights
- Hyperacetylation mimetics within the tau filament core inhibits prion-like propagation of misfolded tau
- Identification of metabolic pathways and key genes associated with atypical parkinsonism using a systems biology approach
- Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620
- Impulse Control Disorders in Parkinson's Disease and Atypical Parkinsonian Syndromes-Is There a Difference?
- In vitro evaluation of [<sup>3</sup>H]PI-2620 and structural derivatives in non-Alzheimer's tauopathies
- In vivo imaging of synaptic density in neurodegenerative disorders with positron emission tomography: A systematic review
- Involvement of Glucosamine 6 Phosphate Isomerase 2 (GNPDA2) Overproduction in β-Amyloid- and Tau P301L-Driven Pathomechanisms
- Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration
- Lateral geniculate body is spared of tau pathology in Pick disease
- Local structural preferences in shaping tau amyloid polymorphism
- Longitudinal change of energy expenditure, body composition and dietary habits in Progressive Supranuclear Palsy patients
- Longitudinal Genotype-Phenotype (Vineland Questionnaire) Characterization of 15 ADNP Syndrome Cases Highlights Mutated Protein Length and Structural Characteristics Correlation with Communicative Abilities Accentuated in Males
- Longitudinal prognosis of Parkinson's outcomes using causal connectivity
- Loss of Mickey Mouse Ears' Sign in Progressive Supranuclear Palsy
- Loss-of-function SMPD1 gene variant in Progressive Supranuclear Palsy-Richardson Syndrome patients of Chinese ancestry
- MAPT H2 haplotype and risk of Pick's disease in the Pick's disease International Consortium: a genetic association study
- Mathematical topology and geometry-based classification of tauopathies
- Molecular Behavior of α-Synuclein Is Associated with Membrane Transport, Lipid Metabolism, and Ubiquitin-Proteasome Pathways in Lewy Body Disease
- Monash-Alfred protocol for assessment of atypical parkinsonian syndromes (MAP-APS)
- Neuromelanin-sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease
- Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer's disease and other neurodegenerative diseases
- Neuropathology of the Neurodegenerative Diseases
- New knowledge on anti-IgLON5 disease
- Novel Insights into the Genetic Basis of Progressive Supranuclear Palsy in Asian-Indian Population
- Phenotypic spectrum of Progressive Supranuclear Palsy: Clinical study and APOE effect
- Planimetric and Volumetric Brainstem MRI Markers in Progressive Supranuclear Palsy, Multiple System Atrophy, and Corticobasal Syndrome. A Systematic Review and Meta-Analysis
- Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies
- Progress in Primary Progressive Aphasia: A Review
- Progressive supranuclear palsy phenotype as an atypical clinical presentation of Creutzfeldt-Jakob disease: A case report and review of the literature
- Proteomic Changes in the Human Cerebrovasculature in Alzheimer's Disease and Related Tauopathies Linked to Peripheral Biomarkers in Plasma and Cerebrospinal Fluid
- Putaminal T1/T2-weighted ratio is increased in PSP compared to PD and healthy controls, a multi-cohort study
- Quantitative brain stem assessment in discriminating neurodegenerative disorders from normal pressure hydrocephalus
- Reduced maximal range of ocular movements and its response to acute levodopa challenge in Parkinson's disease
- Revisiting the relevance of Hirano bodies in neurodegenerative diseases
- Role of Diffusion Tensor Imaging in Early Diagnosis and Characterization of Movement Disorders
- Role of long non-coding RNAs in the pathophysiology of Alzheimer's disease and other dementias
- Seeding Activity of Skin Misfolded Tau as a Biomarker for Tauopathies
- Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan
- Striatal and Extrastriatal Monoaminergic Disruption in Progressive Supranuclear Palsy
- TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43
- The significance of glial cell line-derived neurotrophic factor analysis in Progressive Supranuclear Palsy
- Time to Diagnosis and Its Predictors in Syndromes Associated With Frontotemporal Lobar Degeneration
- Total Patient Delay: A Comparison of Patient and Clinician/Health System Delays in the Diagnosis of Progressive Supranuclear Palsy and Corticobasal Syndrome
- Two distinct degenerative types of nigrostriatal dopaminergic neuron in the early stage of parkinsonian disorders
- Whole-Genome Sequencing Analysis Reveals New Susceptibility Loci and Structural Variants Associated with Progressive Supranuclear Palsy